Business Background CordenPharma manufactures pharmaceuticals for many of the world’s leading pharmacies and biotechnology firms. Over the last several decades, the multinational company has contributed significant advances to Active Pharmaceutical Ingredient (API) manufacturing. Tasked with protecting critical intellectual property in the face of machine-speed cyber-threats, CordenPharma’s security team knew it could no longer rely on the tactics and tools of the past. With the automated attacks we’re up against, we can’t afford to conduct a full investigation before taking action. That’s where Autonomous Response has been indispensable: it puts the time factor back on our side. CordenPharma Challenge Many of CordenPharma’s customers are in early-stage clinical drug trials and

Join for free to read